Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
about
Treating BCG-induced disease in childrenTreatments for BCG-induced disease in childrenAdmixed phylogenetic distribution of drug resistant Mycobacterium tuberculosis in Saudi ArabiaA Case of Bacillus Calmette-Guérin Cystitis Diagnosed with a Novel Loop-mediated Isothermal Amplification Method.Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children.Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis.Successful Handling of Disseminated BCG Disease in a Child with Severe Combined Immunodeficiency.Clinical and laboratory observation of Bacillus Calmette-Guérin infections.Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistanceInfected Aortic Aneurysm caused by Mycobacterium bovis after Intravesical Bacillus Calmette-Guérin Treatment for Bladder CancerTuberculosis in infants: a retrospective study in China.BCG immunotherapy for bladder cancer--the effects of substrain differences.Ethambutol Is Cleared by a Contemporary High-Flux Hemodialyzer, and Drug Monitoring Ensures Safety and Therapeutic Effect.Globalization of pediatric transplantation: The risk of tuberculosis or not tuberculosis.Chest wall abscess due to Mycobacterium bovis BCG after intravesical BCG therapy.Thr270Ile in embC (Rv3793) is not a marker for ethambutol resistance in the Mycobacterium tuberculosis complex.Rifampin-resistant Mycobacterium bovis BCG-induced disease in HIV-infected infant, Vietnam.Activation of type II NADH dehydrogenase by quinolinequinones mediates antitubercular cell death.Molecular Mechanisms of Intrinsic Streptomycin Resistance in Mycobacterium abscessus.Metabolic Activity Interferometer: A Powerful Tool for Testing Antibiotics
P2860
Q24201807-CA96AF4D-2ED1-4FB1-B58A-D3B86200A3DBQ24239915-910DEE10-5A78-4FAC-ABEF-58FEAD32D5BFQ28485907-9343F841-5034-4FEA-B4C5-3ECA844ADEB9Q33869646-12ADC511-2840-4007-8131-D078EE19DB6AQ34542530-8197E192-CEC4-4328-9C54-DB342E713985Q35246507-E18EE481-9680-4C2A-88D7-99ED7120D538Q35450383-C21A633C-C959-48E6-B81A-B2BF8AF9DD28Q35959145-D2B25FEF-4DAB-42D2-BAE8-71AD85532286Q36396241-C2D5B57D-19B5-4233-BF5E-992BCD236DF1Q36472378-BB7ADCD7-D3B7-4376-A7BF-F649CDEBEBEAQ36845115-F666FF8B-3EF6-4471-92E0-F40F22B99067Q38138412-5208223C-6AA2-4667-9D35-9D30D94EABE3Q38843500-1763951F-62A7-4683-B212-9B3D95416972Q38979616-169FE512-39EA-4A2E-B8D5-6748D0BF490BQ40598734-C231B0A8-2ACF-4951-96A2-AFA2BAA1B56DQ42706352-393E8F58-DF22-4011-89BF-7DA08BE8724EQ43088221-9BB52F91-3B76-40F9-BA2C-6F96F990723CQ46524797-A645F29B-E3B3-4813-A40A-1B49B04E8496Q50072876-8ADA84E3-5E2F-4851-816D-B58EECA640C4Q58911119-803015A2-2FBF-42D2-BD72-616CB2F6FFF5
P2860
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
@en
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
@nl
type
label
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
@en
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
@nl
prefLabel
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
@en
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
@nl
P2093
P2860
P50
P356
P1476
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
@en
P2093
Aina Sievers
Marc Tebruegge
Tom G Connell
P2860
P304
P356
10.1128/AAC.01302-08
P407
P577
2008-10-27T00:00:00Z